Connect with us
Our website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

News

Morganti & Co., P.C. – Shareholders Target FSD Pharma Corp

gbafNews28

Morganti & Co., P.C., a cross border shareholders rights law firm, confirms that it has commenced a shareholder class action lawsuit against FSD Pharma Inc. (TSX: HUGE”).

This securities class action relates to the Defendants releasing core and non-core documents which contained omissions of material fact about the status and delays of the build-out of FSD Pharmas 620,000 square foot building in Cobourg, Ontario (the JV Facility), which was to be renovated pursuant to an agreement between FSD Pharma and Auxly Cannabis Group, Inc (TSX: Auxly). The Plaintiff further alleges that the value and price of FSD Pharmas Class B common shares were artificially inflated after the Defendant released each impugned statement alleged to contain a misrepresentation.

On January 8, February 6 and February 8, 2019, the Defendants released statements revealing that Auxly was materially behind schedule and the JV Facility phase one build-out would not be completed until sometime during 2019, that the agreement with Auxly had been abruptly terminated, and that FSD Pharma had terminated its CEO. These public corrective statements resulted in the price for FSDs Class B common shares dropping in price from $0.355 to $0.28 a share, a decrease of over 21%.

Morganti & Co., P.C. has uncovered information that evidences that FSD Pharma and Auxly never had all the proper zoning permits to complete the phase one build-out prior to year end 2018. We have filed this evidence with the court. The next court hearing is scheduled for May 5, 2020.

The shareholders that received marketing materials from Wayland and its underwriters that sold the shares are encouraged to contact the Firm to discuss what those materials disclosed.

About Morganti & Co.

You may learn more about Morganti & Co. online at www.morgantico.com and follow the news about the FSD Pharma shareholder litigation at https://morgantico.com/fsd-pharma-inc/.

The Firm also represents investors in litigation against Aphria Inc. (TSX: APHA), Auxly Cannabis Group Inc. (TSX: XLY), HEXO Corp. (TSX: HEXO), Namaste Technologies Inc. (TSXV: N), and Wayland Group Corp. (TSX: WAYL).

This press release may be considered attorney advertising in some jurisdictions under the applicable law and ethical rules.

Morganti & Co., P.C.

(647) 344-1900

Toronto + Detroit

Andrew Morganti, (248) 787-6078

info@morgantilegal.com

Advertisement
Editorial & Advertiser disclosure

Call for Entries

Global Banking and Finance Review Awards Nominations 2022
2022 Awards now open. Click Here to Nominate

Newsletters with Secrets & Analysis. Subscribe Now

Recommended

Global Banking & Finance Review® is a leading financial portal and Print Magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management. Copyright © 2010-2021 GBAF Publications Ltd - All Rights Reserved.